FDA Drug Application (204096) for ASTAGRAF XL by ASTELLAS

Back to FDA Applications sponsored by ASTELLAS

Application Number204096
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
DosageEQ 0.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameASTAGRAF XL
Active IngredientTACROLIMUS

Active IngredientCount
List of drugs with Active Ingredient TACROLIMUS5


Back to FDA Applications sponsored by ASTELLAS